Synthesis of Thyclotides (R,R) and (S,S)-trans

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation, and a separate written solicitation will not be issued. This solicitation number isNICHD-22-229 and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2022-06. The North American Industry Classification (NAICS) Code is 54138 and the business size standard is $15.0M. It is the intent of The National Institutes of Health, National Institute of Child Health and Development (NICHD), in support of the work of the National Institute of Diabetes, Digestive, and Kidney Disease (NIDDK) to award a purchase order, without providing for full and open competition, to Frontage Laboratories, Inc., 700 Pennsylvania Drive, Exton, PA 19341, for Synthesis of Thyclotides (R,R) and (S,S)-trans-Tetrahydrofuran- constrained peptide nucleic acids.